British drugmaker AstraZeneca Plc has agreed to pay $68.5 million to resolve allegations by U.S. state regulators that its marketing of the multibillion-dollar antipsychotic drug Seroquel was deceptive.
The accord with 37 U.S. states and Washington, D.C., is the largest multistate, consumer protection-based pharmaceutical settlement on record, said Paula Dow, attorney general of New Jersey, which is among the settling states. Get the full story »
